Clinical Trial Update: Doxycycline for the Prevention of Spontaneous Bacterial Peritonitis

View source ↗

Summary

A completed clinical trial evaluated doxycycline for the prevention of spontaneous bacterial peritonitis in patients with cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Spontaneous Bacterial Peritonitis

Drugs mentioned

• Doxycycline (Doxycycline)

Snippet

Sponsor: Methodist Health System | Conditions: Cirrhosis, Spontaneous Bacterial Peritonitis | Status: COMPLETED